Company profile · Sponsor
AB
AB Science
- Pipeline
- 6
- Drugs
- 0
- Patents
- 0
Quick answer
AB (EAFEF9D) is a pharma company. headquartered in PARIS, FR. listed on EMA. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..
Company facts
Pipeline (6)
Search pipeline →-
Placebo to 100mg masitinib, Placebo to 200mg masitinib, masitinib, masitinib
AB
Mastocytosis
1 trial -
RILUTEK 50 mg film-coated tablets, masitinib, Placebo to 200mg masitinib, masitinib, Riluzole Zentiva 50 mg film-coated tablets, Placebo to 100mg masitinib
AB
Amyotrophic Lateral Sclerosis
1 trial -
masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib
AB
Amyotrophic Lateral Sclerosis
1 trial -
masitinib, Placebo to 200mg masitinib, Placebo to 100mg masitinib, masitinib
AB
Multiple Sclerosis
1 trial -
AB8939, Vidaza 25 mg/ml powder for suspension for injection, Venclyxto 100 mg film-coated tablets
AB
Acute Myeloid Leukemia
1 trial -
masitinib, masitinib, Placebo to 100mg masitinib, Placebo to 200mg masitinib
AB
Mast cell activation syndrome
1 trial
Frequently asked questions
What is AB?
AB (EAFEF9D) is a pharma company. headquartered in PARIS, FR. listed on EMA. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..
What pipeline programs does AB sponsor?
We track 6 ClinicalTrials.gov-linked programs for AB, including Placebo to 100mg masitinib, Placebo to 200mg masitinib, masitinib, masitinib and 5 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does AB company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.